Mapping Endogenous Psychedelic Chemistry: Indolethylamine N-Methyltransferase (INMT) Localizes Proximal to the Golgi Apparatus of Human Neurons
This study provides the first protein-level characterization of the DMT-producing enzyme INMT in human neurons, revealing its localization near the cis-Golgi network and suggesting this microdomain serves as a site for endogenous psychedelic tryptamine biosynthesis that can access intracellular 5-HT2A receptors.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer
For decades, scientists have known that the human brain produces a vast array of chemical signals that regulate mood, perception, and behavior. Among these, a group of compounds known as psychedelics has long fascinated researchers, particularly because they can induce profound shifts in consciousness when taken from outside the body. One such compound, N,N-dimethyltryptamine, or DMT, is found in many plants used in traditional ceremonies and is known to powerfully alter human experience. While it has been established that the human body possesses the machinery to create this substance, a critical mystery remained: does the human brain actually make DMT on its own, and if so, where does this happen inside the cell? The answer to this question has been elusive because the enzymes responsible for building these molecules are difficult to find, and the tiny spaces within a neuron where chemical reactions occur are hard to map. Understanding whether the brain produces its own psychedelics is not just a matter of curiosity; it could reveal a hidden layer of how our nervous system maintains its structure and responds to stress, potentially opening new doors for treating mental health conditions.
A team of researchers at Massachusetts General Hospital and Harvard Medical School has now taken a significant step toward solving this puzzle by mapping the location of the key enzyme that builds DMT inside human neurons. Using cells grown in the lab that were derived from human stem cells, the scientists developed a way to see this specific enzyme, called indolethylamine N-methyltransferase, or INMT, for the first time at the protein level. They found that INMT does not float freely throughout the cell as some had assumed. Instead, it sits in a very specific neighborhood: right next to the Golgi apparatus, a central sorting station within the cell that packages and ships proteins. More precisely, the enzyme is located on the outer surface of the early section of this station, known as the cis-Golgi network. This discovery is the first direct evidence of where the human brain's DMT-making machinery is physically positioned.
To reach this conclusion, the researchers first had to ensure they were looking at the right target. They tested a new antibody, a tool designed to stick specifically to the INMT protein, on human cells known to produce it. They confirmed that the antibody worked by showing that when they blocked the antibody with a piece of the protein itself, the signal disappeared, proving the tool was accurate. They then applied this tool to human neurons grown in a dish. Under a microscope, the neurons showed a distinct pattern: the INMT protein appeared as bright, dotted clusters near the center of the cell, rather than a diffuse cloud. This visual clue suggested the enzyme was anchored to a specific organelle. To confirm this, the team compared the location of INMT with the location of other proteins known to mark the Golgi apparatus. They found that the dots of INMT aligned perfectly with the dots of the Golgi marker, sitting side-by-side on the cell's internal membrane system.
The study went further to understand the exact orientation of the enzyme. Cells have membranes that separate their interior from the outside, and proteins can face either the inside of the cell or the space within the membrane-bound compartments. By using a gentle chemical treatment that opened only the outer cell wall without disturbing the internal compartments, the researchers showed that the INMT enzyme faces the fluid inside the cell, the cytosol. This is a crucial detail because the raw materials needed to build DMT are also floating in this fluid. This positioning means the enzyme is perfectly placed to grab these materials and convert them into DMT right where they are available. Furthermore, the researchers found that this enzyme is present in various shapes of the Golgi apparatus, including those that have moved out into the long, thin arms of the neuron, suggesting that DMT production could happen in many different parts of the nerve cell, not just the main body.
The implications of this location are supported by what the researchers found regarding the brain's receptors for these chemicals. They discovered that a specific type of serotonin receptor, which is the target of psychedelic drugs, also exists in small numbers on the Golgi apparatus. While most of these receptors are found on the cell surface or inside the nucleus, a distinct group sits near the Golgi. The study suggests a model where the INMT enzyme creates a local pocket of DMT on the outside of the Golgi. Because DMT can easily pass through cell membranes, it could slip into the Golgi compartment and bind to the receptors waiting there. This process might be a natural way the brain regulates its own structural plasticity, or its ability to change and grow, which is often disrupted in conditions like depression. The researchers also noted that the enzyme's activity might be influenced by the cell's energy state, such as during low oxygen conditions, hinting that the brain might produce more of these compounds during times of stress as a protective measure.
This work does not claim to have solved the entire mystery of endogenous psychedelics, nor does it prove that the brain produces DMT in the same quantities as when a person takes it as a drug. Instead, it provides the first concrete map of the factory floor where this production likely occurs. By showing that the enzyme and the receptor are neighbors in the same cellular district, the study offers a plausible explanation for how the brain could generate and use its own psychedelic-like signals. The findings suggest that the spatial organization of these molecules is just as important as their chemical structure. If the brain's ability to build these compounds is indeed linked to the health of the Golgi apparatus, then disruptions in this cellular sorting center could play a role in neurological diseases. This research transforms the idea of endogenous psychedelics from a theoretical possibility into a physical reality with a defined location, offering a new framework for understanding how the human mind might regulate itself from the inside out.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.